As of March 2024 Adicet Bio has a market cap of $0.19 Billion. This makes Adicet Bio the world's 6991th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.19 B | 136.65% |
2023 | $81.58 M | -78.7% |
2022 | $0.38 B | -44.04% |
2021 | $0.68 B | 147.63% |
2020 | $0.27 B |
On Mar 28th, 2024 the market cap of Adicet Bio was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Novartis NVS | $197.71 B | 102,312.25% | ๐จ๐ญ Switzerland |
Pfizer PFE | $157.13 B | 81,291.24% | ๐บ๐ธ USA |
Merck MRK | $334.18 B | 172,995.70% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.81 B | 8,092.80% | ๐ฎ๐ฑ Israel |
Hawkins HWKN | $1.60 B | 733.25% | ๐บ๐ธ USA |
Quaker Houghton KWR | $3.69 B | 1,812.76% | ๐บ๐ธ USA |